Long-term survival in a patient with metastatic HER2+ breast cancer undergoing lapatinib-based therapy for 6 years
We report the case of a patient with HER2-positive breast cancer under adjuvant therapy (chemotherapy and trastuzumab) who developed a recurrence with bone (cervical spine) and lung involvement. After treatment with lapatinib and capecitabine, the patient remained stable with considerable improvemen...
Main Authors: | Salvatore Turano, Serafino Conforti |
---|---|
Format: | Article |
Language: | English |
Published: |
AboutScience Srl
2018-09-01
|
Series: | AboutOpen |
Subjects: | |
Online Access: | https://journals.aboutscience.eu/index.php/aboutopen/article/view/7 |
Similar Items
-
HER2-positive breast cancer with brain metastasis, long responder to lapatinib therapy
by: Chiara Saggia
Published: (2018-06-01) -
Paziente con carcinoma mammario oligometastatico HER2-positivo, lungosopravvivente in trattamento con lapatinib/ capecitabina dopo resezione e termoablazione polmonare
by: Gennaro Gadaleta-Caldarola
Published: (2017-12-01) -
Lunga sopravvivenza di una paziente con carcinoma mammario HER2-positivo, in trattamento con lapatinib
by: Anna Gambaro
Published: (2017-12-01) -
Sopravvivenza a lungo termine in paziente trattata con lapatinib e capecitabina
by: Carlo Mulas
Published: (2017-12-01) -
Dual HER2 Suppression with Lapatinib plus Trastuzumab for Metastatic Inflammatory Breast Cancer: A Case Report of Prolonged Stable Disease
by: Lauren Ogawa, et al.
Published: (2018-12-01)